Latest News

Tongcheng Travel Holdings (SEHK:780) has wrapped up FY 2025 with fourth quarter revenue of C¥4.8b and basic EPS of C¥0.04, while trailing twelve month revenue stood at C¥19.4b and EPS at C¥1.03. The company has seen revenue move from C¥17.3b to C¥19.4b over the past year on a trailing basis, with EPS rising from C¥0.87 to C¥1.03. Earnings growth was 20.1% over the same period. With trailing net margin at 12.2% and described as supported by high quality earnings, the latest results put...

As the Canadian market navigates a landscape influenced by global economic factors, including the Federal Reserve's cautious approach to interest rates and inflation expectations, investors are closely monitoring growth opportunities. In this environment, stocks with strong insider ownership can be appealing due to potential alignment of interests with shareholders and demonstrated confidence in long-term growth prospects.

As the Canadian market navigates through a landscape of moderated fiscal stimulus and stable inflation expectations, investors are keenly watching for opportunities amidst cautious optimism. In such conditions, penny stocks—though an outdated term—remain relevant as they often represent smaller or less-established companies with potential value. By focusing on those with solid financial foundations and growth potential, investors may uncover promising opportunities within this niche segment...

In the current Canadian market landscape, investors are closely watching inflation expectations and the Federal Reserve's cautious stance on interest rates, as these factors could influence small-cap stocks. Amidst this backdrop, identifying promising yet under-the-radar companies can be a strategic move to enhance portfolio diversification and capitalize on potential growth opportunities.

UNIQA Insurance Group (WBAG:UQA) has drawn fresh attention after reporting full year 2025 net income of €516.4 million versus €441.9 million a year earlier, alongside announcing an annual dividend of €0.72 per share. See our latest analysis for UNIQA Insurance Group. Despite the higher reported net income and the upcoming €0.72 dividend, the recent 30 day share price return of a 12.54% decline to €14.64 suggests some cooling in short term momentum. However, the 1 year total shareholder return...

Shanghai Industrial Urban Development Group (SEHK:563) has reported FY 2025 first half revenue of HK$1,827.8 million, with a basic EPS loss of HK$0.10. This puts the focus firmly on how efficiently that top line is translating into bottom line results. Over the past year of reported periods, revenue has ranged from HK$2,980.8 million in 1H 2024 to HK$9,459.5 million in 2H 2024. Over the same intervals, basic EPS has moved between a loss of HK$0.02 and a loss of HK$0.10, giving investors a...

If you are wondering whether Merit Medical Systems at around US$67.55 is starting to look appealing or still feels expensive, the recent share performance gives you a useful starting point. The stock has seen a 3.8% decline over the last 7 days, a 17.8% fall over the last 30 days, and is down 21.9% year to date and 35.5% over the past year, while the 5 year return stands at 13.4%. These moves have put more attention on how the market currently prices Merit Medical Systems and whether...

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings forecasted to grow by 16% annually. In this context of fluctuating performance, identifying small-cap stocks with potential insider buying can be an intriguing strategy for investors seeking opportunities that may not be immediately apparent in larger market trends.

Kunlun Energy FY 2025 earnings snapshot Kunlun Energy (SEHK:135) has reported fresh numbers for FY 2025, with first half revenue of C¥97.5b and basic EPS of C¥0.37. The company’s revenue moved from C¥94.1b and EPS of C¥0.31 in 2H 2024 to C¥97.5b and C¥0.37 in 1H 2025. Trailing twelve month EPS is C¥0.62 on revenue of C¥195.8b, leaving investors weighing a modest earnings profile against margins that remain relatively thin. See our full analysis for Kunlun Energy. With the headline figures...

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it remains up by 13% over the past year with earnings projected to grow by 16% annually. In this context, identifying stocks that are trading below their intrinsic value can present opportunities for investors seeking to capitalize on potential long-term gains amidst fluctuating market conditions.

The recent 13% drop in Indaptus Therapeutics, Inc.'s ( NASDAQ:INDP ) stock could come as a blow to insiders who...

Fresh off its FY 2025 results, Xiaomi (SEHK:1810) reported fourth quarter revenue of about CN¥116.9b and basic EPS of CN¥0.25, setting the tone for a year where trailing 12 month revenue reached roughly CN¥457.3b and basic EPS came in at CN¥1.62. Over that period, net income excluding extra items totaled about CN¥41.6b, giving investors a clear read on how headline earnings are translating into underlying profitability and where margins are holding up through the latest quarter. See our full...

Over the last 7 days, the U.S. market has dropped by 2.3%, though it has shown a robust increase of 13% over the past year, with earnings projected to grow by 16% annually in the coming years. In such fluctuating conditions, identifying stocks with strong fundamentals and solid balance sheets can be crucial for investors seeking growth opportunities at lower price points. Penny stocks, often representing smaller or newer companies, continue to present underappreciated potential for growth and...

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it has shown resilience with a 13% rise over the past year and earnings are expected to grow by 16% annually. In such dynamic conditions, dividend stocks can offer investors stability and income potential, making them an attractive option for those seeking steady returns amidst market fluctuations.

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Insiders who bought US$1.73m worth of Cartesian Therapeutics, Inc.'s ( NASDAQ:RNAC ) stock at an average buy price of...

Even if it's not a huge purchase, we think it was good to see that Douglas Reynolds, the President of Energy Services...

We feel now is a pretty good time to analyse CollPlant Biotechnologies Ltd.'s ( NASDAQ:CLGN ) business as it appears...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

On March 10, Centrus Energy (NYSE:LEU) adopted amended bylaws addressing new universal proxy rules. The changes clarify shareholder voting standards and tighten requirements for using universal proxy cards in director elections. The board also updated exclusive forum provisions that govern where certain legal disputes must be brought. Centrus Energy is drawing fresh attention after its board revised the company bylaws to align with evolving proxy and legal frameworks. The move comes as the...

We wouldn't blame Viemed Healthcare, Inc. ( NASDAQ:VMD ) shareholders if they were a little worried about the fact that...

Guangzhou Innogen Pharmaceutical Group (SEHK:2591) has reported its FY 2025 first half with revenue of C¥56.4 million, a basic EPS loss of C¥0.29 and net income loss of C¥122.47 million, while trailing twelve month figures show revenue of C¥131.5 million, a basic EPS loss of C¥0.79 and net income loss of C¥341.36 million. The company has seen first half revenue move from C¥0 in FY 2024 to C¥56.4 million in FY 2025 as EPS moved from a basic loss of C¥0.18 to a loss of C¥0.29. This sets up a...

Best Pacific International Holdings (SEHK:2111) has posted its FY 2025 first half results with revenue of HK$2,329.8 million and basic EPS of HK$0.25, setting the tone against a backdrop of forecast earnings growth of about 18.6% per year and revenue growth of roughly 8.8% per year. The company has seen revenue move from HK$2,385.4 million in 1H 2024 to HK$2,675.9 million in 2H 2024 and then to HK$2,329.8 million in 1H 2025, while EPS has shifted from HK$0.27 to HK$0.32 and now HK$0.25. This...

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...